Experimental or Investigational Denial: What to Do
What the Plan Means by Experimental or Investigational
Key Takeaway: The letter is a coverage interpretation under the policy's experimental definition. Pull that definition from the certificate or Evidence of Coverage and answer it line by line. Do not argue a different denial reason than the one printed.
Commercial and Marketplace policies often exclude items they call experimental, investigational, unproven, or not standard of care. The definition may turn on FDA status, published trials, society guidelines, or whether the service is offered only under a research protocol. Two plans can classify the same CPT or drug differently. The controlling text is the booklet that applies to your group or individual contract — not a blog summary and not another insurer's medical policy.
Healthcare.gov's internal-appeals page lists “experimental” or “investigative” treatment among the denials you can internally appeal. File using the forms on the notice, or write with your name, claim number, and member ID, and attach the clinician letter and studies you want considered.
How Is This Different From a Medical-Necessity Denial?
Key Takeaway: Medical necessity asks whether this service is needed for your condition under the plan's clinical criteria. An experimental exclusion asks whether the service itself is covered at all. Mixing the two arguments without quoting the exclusion language is a common miss.
| Denial on the letter | What the plan is deciding | What the packet should answer |
|---|---|---|
| Experimental / investigational | The item is excluded as unproven, even if you have the diagnosis | The plan's own definition, FDA status for your indication, guidelines, and why this is standard care rather than a trial protocol |
| Not medically necessary | The item may be a covered benefit, but the plan says it is not needed for you | Clinical criteria, failed conservative care, and a letter of medical necessity — see medical-necessity denials |
| Both reasons on one notice | Two separate coverage theories | Answer each heading. Do not treat an experimental cite as a typo for medical necessity. |
Can I Appeal an Experimental Denial?
Key Takeaway: Yes, on commercial and Marketplace plans that follow the Healthcare.gov internal-appeal list. If the plan upholds the denial, Healthcare.gov treats experimental or investigational determinations as a type of denial that can go to external review.
File the internal appeal named on the notice within the deadline printed there. Filing windows differ by program — see how long you have to appeal a health insurance denial. Healthcare.gov's external-review page states that types of denials that can go to external review include any denial that involves medical judgment and any denial that involves a determination that a treatment is experimental or investigational. The same page says you generally file the written external-review request within 4 months after the insurer's notice or final determination. The walkthrough is in how to request external review after an insurance denial.
Medicare, Medicaid, and some grandfathered or excepted plans use other tracks. Do not assume ACA external review applies to every card in your wallet.
Need a Draft That Answers the Exclusion?
AppealFlow drafts a medical-necessity-style appeal letter from the denial reason and facts you enter. Quote the experimental definition from your booklet in the draft. You still file on the plan's portal or mail address.
Weak vs. Strong Language on an Experimental Denial
Key Takeaway: Quote the plan's experimental definition, the indication, and the evidence that matches that definition. “My doctor says this is standard” without the policy text leaves the examiner nothing to apply.
| ❌ Weak Request | ✓ Strong Request |
|---|---|
| “This is not experimental. Please approve it.” | “Denial dated [date], claim #[number], reason: experimental/investigational. Certificate section [X] defines experimental as [quote]. [Drug/device/procedure] is FDA-[approved/cleared] for [indication] matching diagnosis [ICD-10]. Attached: labeling, [guideline], clinician letter mapping failed alternatives. Please reverse the exclusion and process under the covered-benefit and medical-necessity rules that remain.” |
| “The FDA approved it, so you have to pay.” | “FDA status is submitted as evidence that this is not an unapproved experiment for the labeled indication. Coverage still follows the plan's experimental definition and remaining criteria. If the plan's objection is off-label use, the cited definition and off-label clause are [quote]; the clinician letter addresses that clause.” |
| “Medicare covers this under my employer's experimental clause.” | “This is a Medicare [Advantage / Original] notice. Coverage follows the applicable NCD/LCD or Medicare Advantage organization determination — not the employer plan's experimental exclusion. I am filing the Medicare process on the notice dated [date].” |
Does FDA Approval Automatically Mean Coverage?
Key Takeaway: No. FDA approval or clearance is evidence that a product is not an unapproved experiment for a labeled indication. Commercial plans may still apply an experimental definition, an off-label exclusion, or medical-necessity criteria. Do not invent an FDA approval that does not exist for your use.
If the labeled indication matches your diagnosis, attach the labeling and say so. If the use is off-label, the appeal is about the plan's off-label and experimental definitions — plus the clinician's rationale and published evidence — not about rewriting the FDA label. If you are enrolled in a clinical trial, say so and attach the protocol information; that can change which costs the plan or Medicare analyzes.
- Denial letter plus the experimental/investigational definition from the certificate or EOC
- FDA labeling or clearance for the indication you actually have, if it exists
- Society guidelines, peer-reviewed studies the clinician cites, and a letter mapping failed alternatives
What If I Have Medicare Instead?
Key Takeaway: Original Medicare coverage follows statute, National Coverage Determinations, Local Coverage Determinations, and Medicare manuals — not your employer's experimental clause. Do not paste a commercial experimental argument into a Medicare redetermination.
CMS describes the Medicare coverage determination process: coverage is limited to items and services that are reasonable and necessary for the diagnosis or treatment of an illness or injury and within a Medicare benefit category. National coverage determinations are made through an evidence-based process. Where there is no national policy, a Medicare contractor may cover or deny under a local coverage determination. Search those documents in the Medicare Coverage Database. Medicare Advantage must cover what Original Medicare covers, with plan rules on top. Medicaid follows the state plan and, for managed care, the handbook.
Do not mix the tracks. A commercial experimental exclusion is a contract clause you appeal under Healthcare.gov internal appeal and, if eligible, external review. An NCD or LCD is a Medicare coverage rule you appeal through the Medicare notice. Filing the wrong letter on the wrong program wastes the deadline.
Frequently Asked Questions
What an experimental or investigational denial means, how it differs from medical necessity, and what to attach on commercial versus Medicare tracks.
Generate a Free Medical Necessity Appeal Draft
AppealFlow.net drafts a letter from the denial reason and facts you enter. Quote the experimental definition from your booklet and attach the clinician evidence. Edit live, download as PDF or Word.
- 100% Free
- No Signup
- PDF & Word Export
Disclaimer: This article is for educational purposes only and does not constitute medical, legal, or financial advice. AppealFlow.net is not a healthcare provider, insurance broker, or law firm. Experimental exclusions, Medicare NCDs/LCDs, and Medicaid rules differ — verify your certificate, denial notice, Healthcare.gov, CMS, or Medicare.gov before you file. For medical emergencies, call 911. See our full disclaimer.